New York-based Pfizer Inc. continued its string of legal victories against India's Ranbaxy Pharmaceuticals Inc., a generic drug maker. Pfizer said Tuesday a U.S. appeals court upheld the imposition of a preliminary injunction against sales of a generic quinapril product manufactured by Ranbaxy and marketed by TevaPharmaceuticals USA Inc. The injunction came in March. Ranbaxy and Teva launched their product in December 2004.

Posted by GEN-ERIC at 12:55:16 am into the following categories: In The News

---

http://gen-eric.com/patents/htsrv/trackback.php/471

Name:

Email: (not displayed on this site)

Site/Url:

Comment text:

Allowed XHTML tags: <p, ul, ol, li, dl, dt, dd, address, blockquote, ins, del, a, span, bdo, br, em, strong, dfn, code, samp, kdb, var, cite, abbr, acronym, q, sub, sup, tt, i, b, big, small>

URLs, email, AIM and ICQs will be converted automatically.

Options:
Auto-BR (Line breaks become <br />)
Remember me (Set cookies for name, email & url)